Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference [Yahoo! Finance]
Anteris Technologies Global Corp. (AVR)
Company Research
Source: Yahoo! Finance
of laminar flow and claimed left-ventricular remodeling (about a 30% LV mass reduction at six months), and a low 3% patient-prosthesis mismatch (PPM) versus ~30% cited for the incumbent balloon-expandable device. PARADIGM pivotal trial is a global, head-to-head randomized study (initially ~1,000 patients, ~500 per arm) designed to support low/medium/high-risk and valve-in-valve labels and includes 4D MRI secondary endpoints to assess flow and LV remodeling. The company emphasizes a balloon-expandable delivery system as critical for adoption and IP protection, and disclosed a strategic Medtronic investment that carries no special rights but could enable future co-development, co-promotion or co-manufacturing discussions. Interested in Anteris Technologies Global Corp.? Here are five stocks we like better. Anteris Technologies Global (NASDAQ:AVR) Chief Executive Officer Wayne Paterson outlined the company's DurAVR transcatheter aortic valve replacement (TAVR) program during a fi
Show less
Read more
Impact Snapshot
Event Time:
AVR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVR alerts
High impacting Anteris Technologies Global Corp. news events
Weekly update
A roundup of the hottest topics
AVR
News
- Anteris Technologies Global (AVR) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $15.00 price target on the stock.MarketBeat
- Anteris Technologies Global (AVR) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $16.00 price target on the stock.MarketBeat
- Anteris Technologies Global (AVR) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
- Anteris Reports 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- Anteris to Present at Healthcare Investor Conferences TD Cowen and BarclaysGlobeNewswire
AVR
Sec Filings
- 3/10/26 - Form POS
- 3/6/26 - Form 4
- 3/3/26 - Form 8-K
- AVR's page on the SEC website